List of Excipients in Branded Drug OXICONAZOLE NITRATE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
E Fougera & Co a division of Fougera Pharmaceuticals Inc	OXICONAZOLE NITRATE	oxiconazole nitrate	0168-0358	BENZOIC ACID
E Fougera & Co a division of Fougera Pharmaceuticals Inc	OXICONAZOLE NITRATE	oxiconazole nitrate	0168-0358	CETYL ALCOHOL
E Fougera & Co a division of Fougera Pharmaceuticals Inc	OXICONAZOLE NITRATE	oxiconazole nitrate	0168-0358	PETROLATUM
E Fougera & Co a division of Fougera Pharmaceuticals Inc	OXICONAZOLE NITRATE	oxiconazole nitrate	0168-0358	POLYSORBATE 60
E Fougera & Co a division of Fougera Pharmaceuticals Inc	OXICONAZOLE NITRATE	oxiconazole nitrate	0168-0358	PROPYLENE GLYCOL

Generic Drugs Containing OXICONAZOLE NITRATE

Company	Ingredient	NDC	Excipient
Taro Pharmaceuticals USA Inc	oxiconazole nitrate	51672-1359	BENZOIC ACID
Taro Pharmaceuticals USA Inc	oxiconazole nitrate	51672-1359	CETYL ALCOHOL
Taro Pharmaceuticals USA Inc	oxiconazole nitrate	51672-1359	PETROLATUM
Taro Pharmaceuticals USA Inc	oxiconazole nitrate	51672-1359	POLYSORBATE 60
Taro Pharmaceuticals USA Inc	oxiconazole nitrate	51672-1359	PROPYLENE GLYCOL

What are the Most Frequently-Used Excipients in OXICONAZOLE NITRATE?

# Of NDCs	Excipient
1	BENZOIC ACID
1	CETYL ALCOHOL
1	PETROLATUM
1	POLYSORBATE 60
1	PROPYLENE GLYCOL

Excipient Strategy and Commercial Opportunities for Oxiconazole Nitrate

Last updated: February 25, 2026

What is the Current Excipient Strategy for Oxiconazole Nitrate?

Oxiconazole nitrate, an imidazole antifungal agent, is formulated mainly as topical creams, solutions, and powders. Its pharmaceutical formulations commonly include excipients that enhance stability, absorption, and user compliance.

Typical Excipients Used

• Cream formulations: Mineral oil, cetostearyl alcohol, stearic acid, cetyl alcohol, and preservatives such as methylparaben.
• Solutions: Ethanol, propylene glycol, and polyethylene glycol.
• Powders: Cornstarch or talc as carriers.

Excipient Selection Criteria

• Compatibility with oxiconazole nitrate to prevent degradation.
• Non-irritating profile to improve patient adherence.
• Enhancing absorption for topical efficacy.
• Providing appropriate consistency and shelf stability.

Challenges in Excipient Optimization

• Ensuring compatibility to prevent hydrolysis or oxidation.
• Balancing viscosity for topical applications.
• Addressing allergic reactions associated with certain preservatives or carriers.

How Can Excipient Strategy Be Innovated?

Novel Excipients and Delivery Systems

• Nanoparticle carriers: Lipid-based nanocarriers or polymeric nanoparticles can improve penetration. Incorporating excipients that stabilize nanocarriers prolongs shelf life.
• Bioadhesive polymers: Use of chitosan or carbomers enhances mucosal adhesion, extending drug contact time.
• Permeation enhancers: Incorporate safe excipients like menthol or urea to increase skin absorption.

Compatibility and Stability Optimization

• Employ excipients with antioxidant properties such as tocopherols to prevent oxidation.
• Use of cyclodextrins to improve solubility and stability of oxiconazole nitrate.

Formulation Improvements

• Controlled-release matrices: Use hydrogels or sustained-release polymers to extend efficacy.
• Waterless or low-water formulations: Reduce hydrolytic degradation risk.

What Are the Commercial Opportunities for Excipient-Driven Formulations?

Market Landscape

• The global antifungal drugs market was valued at USD 14.3 billion in 2022 and is projected to grow at a CAGR of 4.2% through 2030[1].
• Topical antifungal formulations dominate, with cream and ointment segments holding over 70% of the market share.

Innovation and Differentiation

• Formulations with enhanced absorption can command premium pricing.
• Antifungal products with improved stability profiles reduce shelf-life costs.
• Bioadhesive or sustained-release formulations provide added patient convenience.

Patent and Regulatory Opportunities

• Novel excipient combinations and delivery systems can provide patent protection, delaying generic competition.
• Regulatory pathways for excipient modifications are streamlined if safety profiles are established, expanding commercial potential.

Emerging Markets

• Increasing healthcare infrastructure in Asia-Pacific unlocks opportunities for locally adapted formulations.
• Demand for OTC antifungal products creates access points for cost-effective, innovative formulations.

Industry Collaborations

• Partnerships with excipient suppliers can lead to tailored solutions.
• Contract manufacturing organizations (CMOs) can accelerate development timelines for innovative formulations.

What Are the Key Drivers for Excipient Strategy Success?

• Demonstrated safety and tolerability of excipients.
• Compatibility with existing manufacturing processes.
• Evidence of improved efficacy or patient adherence.
• Cost-effective excipient sourcing.

What Risks and Limitations Should Be Managed?

• Regulatory hurdles around new excipients or delivery systems.
• Potential allergenicity of novel excipients.
• Scale-up challenges for advanced formulations.
• Intellectual property landscape complexity.

---

Key Takeaways

• Oxiconazole nitrate formulations rely on excipients that influence stability, absorption, and patient compliance.
• Innovations include nanoparticle carriers, bioadhesive polymers, and controlled-release matrices.
• Commercial success depends on market differentiation, patent protection, and regulatory alignment.
• Emerging markets and OTC segments present growth opportunities.
• Strategic partnerships and careful excipient selection can mitigate risks and accelerate product development.

---

FAQs

1. What excipients are commonly used in oxiconazole nitrate topical formulations?
Mineral oil, cetostearyl alcohol, methylparaben, ethanol, propylene glycol, and talc.

2. How can excipient innovation improve oxiconazole nitrate formulations?
By enhancing drug stability, absorption, and patient adherence through novel delivery systems like nanoparticles or bioadhesive polymers.

3. Are there regulatory challenges in modifying excipient composition?
Yes. Changes in excipients require safety assessments and may trigger regulatory reviews, but if excipients are well-characterized, pathways are streamlined.

4. What market segments offer the highest potential for excipient-driven innovation?
Topical OTC products in emerging markets and formulations with extended-release properties.

5. How does excipient choice impact patent exclusivity?
Novel excipient combinations and delivery technologies can be patented, extending product exclusivity and reducing generic competition.

---

References

[1] Market Research Future. (2022). Global antifungal drugs market forecast to 2030. Retrieved from https://www.marketresearchfuture.com/